GL1X · GenesisL1 explorer

MolNFT v1 · #80631 · protein

Dihydroorotate dehydrogenase (dhodh) crystal structure in complex with small molecule inhibitor

3U2O · Dihydroorotate dehydrogenase (quinone), mitochondrial: “Dihydroorotate dehydrogenase (dhodh) crystal structure in complex with small molecule inhibitor”. X-ray diffraction, 4 ligands (FMN, ORO, 03U), 4 pockets (best druggability…

PDB
3U2O
Type
protein
Length
366 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Dihydroorotate dehydrogenase (quinone), mitochondrial
EC
1.3.5.2
UniProt
Q02127
Ligands
FMN, ORO, 03U, SO4
Pockets
4 · best druggability 0.84

Structure

x-ray diffraction · 1 distinct chain · 47% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADihydroorotate dehydrogenase (quinone), mitochondrial (EC 1.3.5.2)protein36647% helix, 16% strandQ02127

Ligands and binding sites

  • FMN · Flavin mononucleotide · ligand · chains A
  • ORO · Orotic acid · ligand · chains A
  • 03U · methyl 4-{[(2Z)-2-cyano-3-hydroxypent-2-enoyl]amino}-4'-fluorobiphenyl-2-carboxylate · ligand · chains A
  • SO4 · Sulfate ion · ion · 2 copies · chains A
  • ACT · Acetate ion · additive · 3 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15860.840.8974FMN, ORO, 03U
21000.430.7820ACT
3910.420.7921empty
4920.380.7616empty

Compared structures

  • 3U2O · Dihydroorotate Dehydrogenase (DHODH) crystal structure in complex with small molecule… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.